泰凌醫藥：2019年報.pdf

1、AnnualReport年報2019237344269121140142144161163164166167170Financial Highlights財務摘要Chairmans Statement主席報告Management Discussion and Analysis管理層討論及分析Directors and Senior Management董事及高級管理層Corporate Governance Report企業管治報告Environmental,Social and Governance Report環境、社會及管治報告Report of the Directors董事會報告Bo

2、ard of Directors and Board Committees董事會及董事委員會Corporate Information公司資料Independent Auditors Report 獨立核數師報告Consolidated Statement of Profit or Loss綜合損益表Consolidated Statement of Profit or Loss and Other Comprehensive Income綜合損益及其他全面收益表Consolidated Statement of Financial Position綜合財務狀況表Consolidated St

3、atement of Changes in Equity綜合權益變動表Consolidated Statement of Cash Flows綜合現金流量表Notes to the Consolidated Financial Statements綜合財務報表附註CONTENTS 目錄2Financial Highlights財務摘要China NT Pharma Group Company Limited|Annual Report 2019FIVE-YEAR FINANCIAL SUMMARYResultsFor the year ended 31 December截至12月31日止年度2

4、0192018201720162015RMB000RMB000RMB000RMB000RMB000人民幣千元人民幣千元人民幣千元人民幣千元人民幣千元(restated)(restated)（重列）（重列）Turnover營業額365,969571,521604,846359,609217,303Gross profit毛利260,883422,002484,235253,833131,851(Loss)/profit from operations經營（虧損）溢利(479,097)(480,944)269,57864,57571,001(Loss)/profit before taxation

5、除稅前（虧損）溢利(583,472)(561,999)226,42835,54317,456(Loss)/profit for the year from discontinued operations年內來自已終止經營業務 的（虧損）溢利(361,903)(48,916)91,06070,334(Loss)/profit for the year年內（虧損）溢利(593,202)(963,762)161,629115,76087,694 Assets and LiabilitiesAt 31 December於12月31日20192018201720162015RMB000RMB000RMB

6、000RMB000RMB000人民幣千元人民幣千元人民幣千元人民幣千元人民幣千元 Total non-current assets非流動資產總值1,488,9301,637,0711,670,5761,578,145565,635 Total current assets流動資產總值309,344590,0911,089,143984,594832,678Total current liabilities流動負債總額1,625,5171,340,9851,207,0031,367,579495,590 Net current(liabilities)/assets流動（負債）資產淨值(1,31